Annual Shareholders Equity
-$17.58 M
-$21.34 M-566.60%
December 31, 2022
Summary
- As of February 10, 2025, CTIC annual stockholders equity is -$17.58 million, with the most recent change of -$21.34 million (-566.60%) on December 31, 2022.
- During the last 3 years, CTIC annual shareholders equity has fallen by -$41.27 million (-174.20%).
Performance
CTIC Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
-$25.35 M
-$7.77 M-44.21%
March 31, 2023
Summary
- As of February 10, 2025, CTIC quarterly stockholders equity is -$25.35 million, with the most recent change of -$7.77 million (-44.21%) on March 31, 2023.
- Over the past year, CTIC quarterly shareholders equity has increased by +$2.57 million (+9.21%).
Performance
CTIC Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CTIC Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -566.6% | +9.2% |
| 3 y3 years | -174.2% | -135.3% |
| 5 y5 years | -180.6% | -130.6% |
CTIC Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -566.6% | at low | -772.9% | +10.1% |
| 5 y | 5-year | -143.9% | at low | -135.3% | +10.1% |
| alltime | all time | -109.9% | +651.3% | -113.5% | +511.8% |
CTI BioPharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -$25.35 M(+44.2%) |
| Dec 2022 | -$17.58 M(-566.6%) | -$17.58 M(+4.4%) |
| Sep 2022 | - | -$16.84 M(+219.2%) |
| Jun 2022 | - | -$5.27 M(-81.1%) |
| Mar 2022 | - | -$27.92 M(-841.1%) |
| Dec 2021 | $3.77 M(-90.6%) | $3.77 M(-90.3%) |
| Sep 2021 | - | $38.89 M(-37.0%) |
| Jun 2021 | - | $61.71 M(+131.5%) |
| Mar 2021 | - | $26.65 M(-33.4%) |
| Dec 2020 | $40.03 M(+69.0%) | $40.03 M(-14.5%) |
| Sep 2020 | - | $46.82 M(-17.7%) |
| Jun 2020 | - | $56.86 M(-20.8%) |
| Mar 2020 | - | $71.79 M(+203.1%) |
| Dec 2019 | $23.69 M(-59.6%) | $23.69 M(-25.9%) |
| Sep 2019 | - | $31.95 M(-21.6%) |
| Jun 2019 | - | $40.74 M(-19.1%) |
| Mar 2019 | - | $50.34 M(-14.2%) |
| Dec 2018 | $58.69 M(+169.1%) | $58.69 M(+2.8%) |
| Sep 2018 | - | $57.12 M(-17.7%) |
| Jun 2018 | - | $69.39 M(-16.2%) |
| Mar 2018 | - | $82.78 M(+279.5%) |
| Dec 2017 | $21.81 M(+63.8%) | $21.81 M(-36.1%) |
| Sep 2017 | - | $34.13 M(-23.5%) |
| Jun 2017 | - | $44.61 M(-1048.4%) |
| Mar 2017 | - | -$4.70 M(-135.3%) |
| Dec 2016 | $13.32 M(-74.4%) | $13.32 M(-25.6%) |
| Sep 2016 | - | $17.89 M(-57.4%) |
| Jun 2016 | - | $41.95 M(-29.7%) |
| Mar 2016 | - | $59.68 M(+14.7%) |
| Dec 2015 | $52.03 M(+24.6%) | $52.03 M(-323.5%) |
| Sep 2015 | - | -$23.28 M(+97.4%) |
| Jun 2015 | - | -$11.79 M(-166.7%) |
| Mar 2015 | - | $17.68 M(-57.7%) |
| Dec 2014 | $41.76 M(-7.6%) | $41.76 M(+120.0%) |
| Sep 2014 | - | $18.98 M(+102.5%) |
| Jun 2014 | - | $9.37 M(-63.7%) |
| Mar 2014 | - | $25.83 M(-42.8%) |
| Dec 2013 | $45.17 M(+30.7%) | $45.17 M(+1654.3%) |
| Sep 2013 | - | $2.58 M(+52.3%) |
| Jun 2013 | - | $1.69 M(-90.6%) |
| Mar 2013 | - | $17.94 M(-48.1%) |
| Dec 2012 | $34.55 M(+20.3%) | $34.55 M(-484.5%) |
| Sep 2012 | - | -$8.99 M(-36.3%) |
| Jun 2012 | - | -$14.10 M(-208.6%) |
| Mar 2012 | - | $12.98 M(-54.8%) |
| Dec 2011 | $28.72 M(-705.1%) | $28.72 M(+78.1%) |
| Sep 2011 | - | $16.12 M(+365.3%) |
| Jun 2011 | - | $3.46 M(-28.9%) |
| Mar 2011 | - | $4.87 M(-202.6%) |
| Dec 2010 | -$4.75 M(-74.4%) | -$4.75 M(-11.5%) |
| Sep 2010 | - | -$5.36 M(-208.9%) |
| Jun 2010 | - | $4.92 M(-149.7%) |
| Mar 2010 | - | -$9.90 M(-46.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | -$18.56 M(-85.9%) | -$18.56 M(+61.8%) |
| Sep 2009 | - | -$11.47 M(-80.1%) |
| Jun 2009 | - | -$57.52 M(-50.4%) |
| Mar 2009 | - | -$115.93 M(-12.2%) |
| Dec 2008 | -$132.06 M(+22.4%) | -$132.06 M(-1.0%) |
| Sep 2008 | - | -$133.38 M(-0.6%) |
| Jun 2008 | - | -$134.21 M(+17.5%) |
| Mar 2008 | - | -$114.19 M(+5.8%) |
| Dec 2007 | -$107.89 M(+6.2%) | -$107.89 M(-9.6%) |
| Sep 2007 | - | -$119.35 M(+16.9%) |
| Jun 2007 | - | -$102.08 M(-4.5%) |
| Mar 2007 | - | -$106.91 M(+5.2%) |
| Dec 2006 | -$101.60 M(-5.1%) | -$101.60 M(+19.3%) |
| Sep 2006 | - | -$85.14 M(-16.7%) |
| Jun 2006 | - | -$102.17 M(+3.3%) |
| Mar 2006 | - | -$98.94 M(-7.6%) |
| Dec 2005 | -$107.10 M(+51.5%) | -$107.10 M(-30.9%) |
| Sep 2005 | - | -$155.07 M(+5.1%) |
| Jun 2005 | - | -$147.54 M(+34.1%) |
| Mar 2005 | - | -$110.02 M(+55.6%) |
| Dec 2004 | -$70.71 M(-14.3%) | -$70.71 M(+36.7%) |
| Sep 2004 | - | -$51.72 M(-20.8%) |
| Jun 2004 | - | -$65.31 M(+123.9%) |
| Mar 2004 | - | -$29.17 M(-64.7%) |
| Dec 2003 | -$82.54 M(-289.8%) | -$82.54 M(+76.2%) |
| Sep 2003 | - | -$46.85 M(+171.2%) |
| Jun 2003 | - | -$17.28 M(-230.4%) |
| Mar 2003 | - | $13.25 M(-69.5%) |
| Dec 2002 | $43.48 M(-60.3%) | $43.48 M(+269.0%) |
| Sep 2002 | - | $11.78 M(-73.8%) |
| Jun 2002 | - | $44.99 M(-47.6%) |
| Mar 2002 | - | $85.81 M(-21.7%) |
| Dec 2001 | $109.56 M(-38.4%) | $109.56 M(-16.9%) |
| Sep 2001 | - | $131.80 M(-13.1%) |
| Jun 2001 | - | $151.75 M(-9.1%) |
| Mar 2001 | - | $166.94 M(-6.2%) |
| Dec 2000 | $177.94 M(+751.4%) | $177.94 M(-5.1%) |
| Sep 2000 | - | $187.55 M(+227.6%) |
| Jun 2000 | - | $57.25 M(-13.9%) |
| Mar 2000 | - | $66.47 M(+218.0%) |
| Dec 1999 | $20.90 M(-55.7%) | $20.90 M(+6.6%) |
| Sep 1999 | - | $19.60 M(-33.3%) |
| Jun 1999 | - | $29.40 M(-25.0%) |
| Mar 1999 | - | $39.20 M(-16.9%) |
| Dec 1998 | $47.20 M(-34.3%) | $47.20 M(-14.2%) |
| Sep 1998 | - | $55.00 M(-9.2%) |
| Jun 1998 | - | $60.60 M(-7.8%) |
| Mar 1998 | - | $65.70 M(-8.5%) |
| Dec 1997 | $71.80 M(+139.3%) | $71.80 M(+57.5%) |
| Sep 1997 | - | $45.60 M(-7.7%) |
| Jun 1997 | - | $49.40 M(-9.0%) |
| Mar 1997 | - | $54.30 M |
| Dec 1996 | $30.00 M | - |
FAQ
- What is CTI BioPharma annual stockholders equity?
- What is the all time high annual shareholders equity for CTI BioPharma?
- What is CTI BioPharma annual shareholders equity year-on-year change?
- What is CTI BioPharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for CTI BioPharma?
- What is CTI BioPharma quarterly shareholders equity year-on-year change?
What is CTI BioPharma annual stockholders equity?
The current annual shareholders equity of CTIC is -$17.58 M
What is the all time high annual shareholders equity for CTI BioPharma?
CTI BioPharma all-time high annual stockholders equity is $177.94 M
What is CTI BioPharma annual shareholders equity year-on-year change?
Over the past year, CTIC annual stockholders equity has changed by -$21.34 M (-566.60%)
What is CTI BioPharma quarterly stockholders equity?
The current quarterly shareholders equity of CTIC is -$25.35 M
What is the all time high quarterly shareholders equity for CTI BioPharma?
CTI BioPharma all-time high quarterly stockholders equity is $187.55 M
What is CTI BioPharma quarterly shareholders equity year-on-year change?
Over the past year, CTIC quarterly stockholders equity has changed by +$2.57 M (+9.21%)